Ftse Mib
38.307,01
1,61%
DAX
22.735,95
1,88%
S&P 500
5.572,07
0,00%
NASDAQ
17.436,10
0,00%
Bitcoin
83.922,49
1,30%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Evaxion Biotech AS (EVAX) Evaxion Biotech AS (EVAX) Notizie

Evaxion Biotech AS

EVAX
1,86
-0,05 (-2,62%)
Pre Mercato
Ultimo aggiornamento: 13:34:50
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
04/3/202514:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/3/202514:00GLOBEEvaxion to present at numerous upcoming conferences
25/2/202514:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/2/202514:00GLOBEEvaxion extends phase 2 trial with personalized cancer..
14/2/202514:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/2/202514:00GLOBENasdaq confirms Evaxion is fully compliant, withdraws..
12/2/202514:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/1/202522:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/1/202522:05GLOBEEvaxion announces closing of $10.8 million public offering
31/1/202512:33EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
30/1/202514:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/1/202514:00GLOBEEvaxion announces pricing of $10.8 million public offering
30/1/202506:15EDGAR2Form EFFECT - Notice of Effectiveness
28/1/202522:34EDGAR2Form F-1/A - Registration statement for certain foreign..
28/1/202514:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/1/202514:15GLOBEEvaxion granted 180-day compliance extension by Nasdaq as it..
27/1/202514:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/1/202512:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/1/202514:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/1/202514:00GLOBEEvaxion completes dosing in phase 2 trial with personalized..
14/1/202522:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/1/202522:05GLOBEEvaxion announces completion of ADS ratio change
10/1/202514:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/1/202514:00GLOBEEvaxion announces extension to January 14, 2025, of plan to..
07/1/202515:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/12/202414:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/12/202414:00GLOBEEvaxion announces plan to implement ADS ratio change
26/12/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/12/202423:09EDGAR2Form F-1/A - Registration statement for certain foreign..
17/12/202414:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/12/202414:00GLOBEEvaxion pursues agreement with EIB to bolster equity through..
12/12/202414:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/12/202414:00GLOBEEvaxion establishes new AI-derived precision cancer vaccine..
09/12/202415:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/12/202414:00GLOBEEvaxion announces 2025 milestones reflecting continued..
05/12/202422:53EDGAR2Form F-1/A - Registration statement for certain foreign..
03/12/202412:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/12/202414:00GLOBEEvaxion to present preclinical Proof-of-Concept for..
18/11/202422:30EDGAR2Form F-1 - Registration statement for certain foreign..
13/11/202415:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/11/202414:00GLOBEEvaxion receives and appeals delisting determination from..
13/11/202413:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/11/202413:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/11/202414:00GLOBEEvaxion announces positive preclinical data for..
31/10/202415:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/10/202413:00GLOBEEvaxion announces business update and third quarter 2024..
28/10/202414:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/10/202413:00GLOBEEvaxion to announce business update and third quarter 2024..
09/10/202417:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/10/202414:00GLOBEStrong validation of Evaxion’s AI-Immunology™ platform in..
Apertura: Min: Max:
Chiusura: 1,91

La tua Cronologia

NASDAQ
EVAX
Evaxion Biotech AS
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci